These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20557133)

  • 1. Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.
    Quan LD; Yuan F; Liu XM; Huang JG; Alnouti Y; Wang D
    Mol Pharm; 2010 Aug; 7(4):1041-9. PubMed ID: 20557133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and Biodistribution Studies of HPMA Copolymer Conjugates in an Aseptic Implant Loosening Mouse Model.
    Wei X; Li F; Zhao G; Chhonker YS; Averill C; Galdamez J; Purdue PE; Wang X; Fehringer EV; Garvin KL; Goldring SR; Alnouti Y; Wang D
    Mol Pharm; 2017 May; 14(5):1418-1428. PubMed ID: 28343392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.
    Quan LD; Purdue PE; Liu XM; Boska MD; Lele SM; Thiele GM; Mikuls TR; Dou H; Goldring SR; Wang D
    Arthritis Res Ther; 2010; 12(5):R170. PubMed ID: 20836843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis.
    Liu XM; Quan LD; Tian J; Alnouti Y; Fu K; Thiele GM; Wang D
    Pharm Res; 2008 Dec; 25(12):2910-9. PubMed ID: 18649124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice.
    Wei X; Zhao G; Wang X; Gautam N; Jia Z; Zhao Z; Kong D; Zhang F; Kumar S; Sun Y; Chen N; Wang X; Yang L; Ren R; Thiele GM; Bronich TK; O'Dell JR; Alnouti Y; Wang D
    Nanomedicine; 2020 Oct; 29():102266. PubMed ID: 32679269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis.
    Liu XM; Quan LD; Tian J; Laquer FC; Ciborowski P; Wang D
    Biomacromolecules; 2010 Oct; 11(10):2621-8. PubMed ID: 20831200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model.
    Quan L; Zhang Y; Dusad A; Ren K; Purdue PE; Goldring SR; Wang D
    Pharm Res; 2016 Jan; 33(1):186-93. PubMed ID: 26286188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects.
    Ren K; Dusad A; Yuan F; Yuan H; Purdue PE; Fehringer EV; Garvin KL; Goldring SR; Wang D
    J Control Release; 2014 Feb; 175():1-9. PubMed ID: 24326124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.
    Wang D; Miller SC; Liu XM; Anderson B; Wang XS; Goldring SR
    Arthritis Res Ther; 2007; 9(1):R2. PubMed ID: 17233911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis.
    Jia Z; Zhao G; Wei X; Kong D; Sun Y; Zhou Y; Lele SM; Fehringer EV; Garvin KL; Goldring SR; Wang D
    J Control Release; 2020 Aug; 324():560-573. PubMed ID: 32445658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis.
    Rubanová D; Skoroplyas S; Libánská A; Randárová E; Bryja J; Chorvátová M; Etrych T; Kubala L
    Nanomedicine; 2024 Jan; 55():102716. PubMed ID: 38738529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermoresponsive polymeric dexamethasone prodrug for arthritis pain.
    Zhao G; Ren R; Wei X; Jia Z; Chen N; Sun Y; Zhao Z; Lele SM; Zhong HA; Goldring MB; Goldring SR; Wang D
    J Control Release; 2021 Nov; 339():484-497. PubMed ID: 34653564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis.
    Earp JC; Pyszczynski NA; Molano DS; Jusko WJ
    Biopharm Drug Dispos; 2008 Sep; 29(6):366-72. PubMed ID: 18613033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.
    Wang Q; Jiang J; Chen W; Jiang H; Zhang Z; Sun X
    J Control Release; 2016 May; 230():64-72. PubMed ID: 27057749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular Dexamethasone Prodrug Ameliorates Neuroinflammation and Prevents Bone Loss Associated with Traumatic Brain Injury.
    Wei X; Zhao G; Jia Z; Zhao Z; Chen N; Sun Y; Kelso M; Rathore G; Wang D
    Mol Pharm; 2022 Nov; 19(11):4000-4009. PubMed ID: 36042532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Development of a Macromolecular Analgesic for Arthritic Pain.
    Weber L; Wang X; Ren R; Wei X; Zhao G; Yang J; Yuan H; Pang H; Wang H; Wang D
    Mol Pharm; 2019 Mar; 16(3):1234-1244. PubMed ID: 30702897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.
    Wei X; Wu J; Zhao G; Galdamez J; Lele SM; Wang X; Liu Y; Soni DM; Purdue PE; Mikuls TR; Goldring SR; Wang D
    Mol Pharm; 2018 Aug; 15(8):3456-3467. PubMed ID: 29966420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
    Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
    J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
    Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
    Zhou Z; Li L; Yang Y; Xu X; Huang Y
    Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.